Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer-Reference-Cited by-同舟云学术

Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer

Published:2023-10 Issue: Volume:170 Page:142-154
ISSN:1742-7061
Container-title:Acta Biomaterialia
language:en
Short-container-title:Acta Biomaterialia

Author:

Diniz Francisca^ORCID,Lamas Sofia^ORCID,Osório Hugo^ORCID,Aguiar Paulo^ORCID,Freitas Daniela^ORCID,Gärtner Fátima,Sarmento Bruno^ORCID,Reis Celso A.,Gomes Joana

Publisher

Elsevier BV

Subject

Molecular Biology,Biomedical Engineering,Biochemistry,Biomaterials,General Medicine,Biotechnology

Reference65 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Lordick;Ann. Oncol.,2022

3. Emerging targeted therapies for HER2 positive gastric cancer that can overcome trastuzumab resistance;Mitani;Cancers,2020

4. Trastuzumab for gastric cancer treatment;Fujita;Lancet North Am. Ed.,2010

5. MET Expression and amplification in patients with localized gastric CancerMET in gastric cancer;Janjigian;Cancer Epidemiol. Biomarkers Prev.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies;Frontiers in Oncology;2024-09-13

2. Atomic Force Microscopy Lifetime Analysis: An Intuitive Method for Evaluating Receptor Tyrosine Kinase Dimer-Targeting Inhibitors;Analytical Chemistry;2024-06-26

3. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15

4. Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer;International Journal of Molecular Sciences;2024-03-19

5. MAGOH promotes gastric cancer progression via hnRNPA1 expression inhibition-mediated RONΔ160/PI3K/AKT signaling pathway activation;Journal of Experimental & Clinical Cancer Research;2024-01-25